Hledání článků
Filtry
Gitomer BY, Ostrow A, Wang W, et al. A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early‑stage autosomal dominant polycystic kidney disease.
Kidney Int 2026;109:390–397.
Syeda H, Doan V, Shoker A, Abdelrasoul A. Molecular frontiers in hemodialysis: unraveling the role of membranes in gene expression, epigenetics, and inflammatory pathways.
Int Urol Nephrol 2025;57:4177–4208.
Lok CE, Farkouh M, Hemmelgarn BR, et al. Fish‑oil supplementation and cardiovascular events in patients receiving hemodialysis.
N Engl J Med 2026;394:128–137.
Ortiz A, Kramer A, Stel VS. Over 500,000 people on kidney replacement therapy in the European Union.
Nephrol Dial Transplant 2026 Feb 6:gfag017. Doi: 10.1093/ndt/gfag017. Epub ahead of print.
Katz‑Greenberg G, Afshar Y, Bonn J, et al. Pregnancy after solid organ transplantation: Review of the evidence and recommendations.
Transplantation 2025;109:1483–1494.
Neuen BL, Fletcher RA, Anker SD, et al. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta‑Analysis.
JAMA 2025 Nov 7:e2520834. Doi:10.1001/jama.2025.20834. Online ahead of print.
Fanouriakis A, Kostopoulou M, Anders HJ, et al. EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.
Ann Rheum Dis 2025 Oct 16:S0003‑4967(25)04412‑7. doi: 10.1016/j.ard.2025.09.007. Epub ahead of print.
Perkovic V, Trimarchi H, Tesar V, et al. Sibeprenlimab in IgA nephropathy – interim analysis of a phase 3 trial. N Engl J Med 2025 Nov 8. doi: 10.1056/NEJMoa2512133. Online ahead of print.
Lafayette R, Barbour SJ, Brenner RM, et al. A phase 3 trial of atacicept in patients with IgA nephropathy. N Engl J Med 2025 Nov 6. doi: 10.1056/NEJMoa251098. Online ahead of print.
Am J Kidney Dis 2025;85:465–476.
Chewcharat A, Nigwekar SU. Ten tips on how to deal with calciphylaxis patients.
Clin Kidney J 2025;18:sfaf098.